Size matters: A comparison of T1 and T2 peripheral non–small-cell lung cancers treated with stereotactic body radiation therapy (SBRT) Neal E. Dunlap,

Slides:

Advertisements

Similar presentations

Lost in translation The Journal of Thoracic and Cardiovascular Surgery

Advertisements

Manuel J. Antunes, MD, PhD, DSc

The eighth edition TNM stage classification for lung cancer: What does it mean on main street? Frank C. Detterbeck, MD The Journal of Thoracic and Cardiovascular.

Michael Y. Chang, MD, MPH, Steven J. Mentzer, MD, Yolonda L

One in every 14 patients with early-stage lung cancer is not being treated! Benny Weksler, MD, MBA The Journal of Thoracic and Cardiovascular Surgery

It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible Alessandro Brunelli,

Disparities in Treatment of Patients with Inoperable Stage I Non–Small Cell Lung Cancer: A Population-Based Analysis Matthew Koshy, MD, Renuka Malik,

Effect of tumor size on prognosis in patients with non–small cell lung cancer: The role of segmentectomy as a type of lesser resection Morihito Okada,

Michael C. Roach, MD, Gregory M. M. Videtic, MD, CM, FRCPC, Jeffrey D

Lung cancer screening: No more excuses

Impact of tumor size on outcomes after anatomic lung resection for stage 1A non–small cell lung cancer based on the current staging system Shamus R.

Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer Hong.

Matthew J. Boyer, MD, PhD, Christina D. Williams, PhD, MPH, David H

Ground glass opacity of the lung: The veil that needs lifting

Circulating tumor DNA: Solid data from liquid biopsies

Intrinsic cardiac stem cells are essential for regeneration

Joshua E. Rosen, BASc, Michelle C

William M. DeCampli, MD, PhD

Central versus Peripheral Tumor Location: Influence on Survival, Local Control, and Toxicity Following Stereotactic Body Radiotherapy for Primary Non–Small-Cell.

Patterns of survival and recurrence after surgical treatment of early stage non–small cell lung carcinoma in the ACOSOG Z0030 (ALLIANCE) trial Stacey.

A bilobed thoracic outlet mass: Options for resection

The lord of the rings Antonio Miceli, MD, PhD

Elizabeth A. David, MD, MAS, Stina W. Andersen, PhD, Laurel A

Is tissue the issue? Brian E. Louie, MD, MHA, MPH, FRCSC, FACS

Treatment trends in early-stage lung cancer in the United States, 2004 to 2013: A time- trend analysis of the National Cancer Data Base Kathryn E. Engelhardt,

A systematic review and meta-analysis of stereotactic body radiation therapy versus surgery for patients with non–small cell lung cancer Christopher.

Yang Zhang, MD, Haiquan Chen, MD, PhD

Impact of positive pleural lavage cytology on survival in patients having lung resection for non–small-cell lung cancer: An international individual patient.

The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery Vinay Badhwar, MD The Journal of Thoracic and.

It's not “just a shunt” but sometimes it should be…

Fixing the supply problem

Management of stage IIIA (N2) non–small cell lung cancer: A transatlantic perspective Gaetano Rocco, MD, Katie Nason, MD, MPH, Alex Brunelli, MD, Gonzalo.

Military surgeons just want to have fun

A first start for lung transplantation?

Commentary: Tag, you're it

Transcatheter aortic valve replacement and surgical aortic valve replacement: Both excellent therapies J. James Edelman, MBBS(Hons), PhD, Vinod H. Thourani,

Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD

Michael Lanuti, MD The Journal of Thoracic and Cardiovascular Surgery

Yusuke Takahashi, MD, PhD, Prasad S. Adusumilli, MD

Resection of primary lung cancer with incidental pleural seeding: Seeds of change or reap what you sow? Jules Lin, MD The Journal of Thoracic and Cardiovascular.

Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD

Attachment disorder in thoracoabdominal surgery

Uma M. Sachdeva, MD, PhD, Daniela Molena, MD

Video-assisted resection for lung cancer results in fewer complications Lunxu Liu, PhD, MD, FRCS The Journal of Thoracic and Cardiovascular Surgery

Marginal pulmonary function should not preclude lobectomy in selected patients with non–small cell lung cancer Matthew D. Taylor, MD, Damien J. LaPar,

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Prognosis and “granularity”: Building on staging foundations?

James I. Fann, MD, John E. Connolly, MD

Innovation in cardiothoracic surgical training

The origins of open heart surgery at the University of Minnesota 1951 to 1956 Richard A. DeWall, MD The Journal of Thoracic and Cardiovascular Surgery

Bryan M. Burt, MD The Journal of Thoracic and Cardiovascular Surgery

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

The future of cardiac surgery training: A survival guide

Apparently, size matters…in congenital heart disease and brain injury

Linda W. Martin, MD, MPH, FCCP, FACS, Gail E

Robert J. Cerfolio, MD, FACS, FCCP, Ayesha S. Bryant, MSPH, MD

The continuing challenge of congenital heart disease in China

Maral Ouzounian, MD, PhD, Amine Mazine, MD, MSc, Tirone E. David, MD

Size matters: A comparison of T1 and T2 peripheral non–small-cell lung cancers treated with stereotactic body radiation therapy (SBRT) Neal E. Dunlap,

“The more things change…”: The challenges ahead

Toward a more rational approach in treating type B aortic dissection

Aritoshi Hattori, MD, Kenji Suzuki, MD

Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery Raja M. Flores, MD The Journal.

Preoperative PFTs: The answer is blowing in the wind

Who should decide margin length in pulmonary excision of lung cancer?

Did you like Terminator 3 better than Terminator 2

Samuel Kim, MD The Journal of Thoracic and Cardiovascular Surgery

A good chimney requires a good sweep

Reappraise the advanced technique for tumor localization and sentinel lymph node assessment in clinical early-stage non–small cell lung cancer Chengwu.

Presentation transcript:

Size matters: A comparison of T1 and T2 peripheral non–small-cell lung cancers treated with stereotactic body radiation therapy (SBRT) Neal E. Dunlap, MD, James M. Larner, MD, Paul W. Read, MD, PhD, Benjamin D. Kozower, MD, Christine L. Lau, MD, Ke Sheng, PhD, David R. Jones, MD The Journal of Thoracic and Cardiovascular Surgery Volume 140, Issue 3, Pages 583-589 (September 2010) DOI: 10.1016/j.jtcvs.2010.01.046 Copyright © 2010 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Representative helical TomoTherapy SBRT treatment plan with isodose lines and corresponding BED. The Journal of Thoracic and Cardiovascular Surgery 2010 140, 583-589DOI: (10.1016/j.jtcvs.2010.01.046) Copyright © 2010 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Local control by T-stage grouping. The Journal of Thoracic and Cardiovascular Surgery 2010 140, 583-589DOI: (10.1016/j.jtcvs.2010.01.046) Copyright © 2010 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Overall survival by T-stage grouping. The Journal of Thoracic and Cardiovascular Surgery 2010 140, 583-589DOI: (10.1016/j.jtcvs.2010.01.046) Copyright © 2010 The American Association for Thoracic Surgery Terms and Conditions